Chao-Chi Wang, MSc

PhD student
Laboratory of Experimental Oncology, KU Leuven, Belgium

PhD student at Laboratory of Experimental Oncology, KU Leuven, Department of Oncology; Leuven Cancer Institute
Focusing on establishment and characterization of patient-derived xenografts of soft tissue sarcoma, and in vivo drug testing

Soft tissue sarcoma; patient-derived xenograft models; antibody-drug conjugates, in vivo, drug testing

chao-chi.wang@kuleuven.be
Onderwijs en Navorsing 4 Herestraat 49, 3000 Leuven Belgium

Poster(s):

• (P 331) EFFICACY OF NOVEL UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-ASSOCIATED PROTEIN TARGETED ANTIBODY-DRUG CONJUGATES IN PATIENT-DERIVED XENOGRAFTS OF SOFT TISSUE SARCOMA

• (P 334) EXPANDING THE LANDSCAPE OF PRECLINICAL MODELS OF SYNOVIAL SARCOMA: FROM 2-DIMENSIONS TO 3-DIMENSIONS TO MICE

• (P 340) THE DNA MINOR GROOVE BINDING AGENTS ECUBECTEDIN AND PM54 DEMONSTRATE ANTITUMOR ACTIVITY IN PATIENT-DERIVED XENOGRAFT MODELS OF SOFT TISSUE SARCOMA